CME/CE credit: 5 AMA PRA Category 1 CreditsTM
Length of time for completion: 5+ hours
Number of questions to complete: All available questions
Planning Committee, Writers, and Reviewers/Faculty:
Amy Rontal, MD: Planner, Reviewer
Previous Director of Medical Content, Blueprint Test Prep/Rosh Review
Assistant Professor of Emergency Medicine
Beaumont Health Systems/Oakland University
Jessica Pearce, DO: Planner, Writer, Reviewer
OB/GYN Content Champion, Blueprint Test Prep/Rosh Review
Texas Health Presbyterian Hospital Dallas, TX
Melinda Chen, MD: Reviewer
Internal Medicine Content Champion, Blueprint Test Prep/Rosh Review
University of California, San Diego – Department of Medicine, Division of General Internal Medicine
Yi-Kuan Chen, MD: Reviewer
Family Medicine Physician
Family Medicine Content Champion, Blueprint Test Prep/Rosh Review
Target Audience: Physicians
Learning Objectives: Upon completion of this educational activity, participants will be able to:
- Comprehensively review the diagnosis, treatment, and high-risk scenarios surrounding hormone therapy decisions and menopause.
- Effectively translate the acquired academic knowledge into improved diagnostics and subsequently implement a better treatment plan for all menopause patients.
Accreditation:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Wayne State University School of Medicine and Rosh Review. The Wayne State University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Designation of Credit:
The Wayne State University School of Medicine designates this enduring material for a maximum of 5 AMA PRA Category 1 CreditsTM. Participants should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure Information
Disclosures: Wayne State University School of Medicine requires that everyone who is in a position to control the content of an education activity disclose all financial relationships with ineligible companies. “Ineligible companies” are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
No commercial relationships with eligible companies:
Amy Rontal, MD
Jessica Pearce, DO
Melinda Chen, MD
Yi-Kuan Chen, MD
Investigational and/or Off-Label Use of Commercial Products and Devices:
There is no mention of investigational and/or off-label use of commercial products.
Acknowledgment of Commercial Support: There is no commercial support received for this educational activity.
Technical Requirements: Internet connection
For CME-related questions about this activity, contact Taylor Lauzon at cme@roshreview.com